18F-LNC1006

N/A

Report date: 2025/11/14 09:32:50

NME

Base Information

Drug Name18F-LNC1006

Drug Alias Name18F-LNC100618F-LNC-1006

ClassificationSmall molecules > Synthetic peptideRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionPositron-emission tomography enhancersAlbumins replacements

TargetsAlbumins

Therapy Area/IndicationsLymphedema

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesYantai Lannacheng Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesYantai Lannacheng Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsLymphedema

Inactive IndicationsN/A

Other Information

ATC CodeN/A